Expert Opinion On Drug Safety

Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase (R)

The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma

Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system

Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and meta-analysis

Safety of drugs used for the treatment of Crohn's disease

An update on the problem of osteoporosis in people with epilepsy taking antiepileptic drugs

A narrative review of problems with medicines use in people with dementia

Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysis

Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation

The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis